IKNA – ikena oncology, inc. (US:NASDAQ)
Stock Stats
News
Ikena Oncology, Inc. (NASDAQ: IKNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) [Yahoo! Finance]
Ikena Oncology Reports Third Quarter 2024 Financial Results
Form SC 13G Ikena Oncology, Inc. Filed by: Blue Owl Capital Holdings LP
Form SC 13G/A Ikena Oncology, Inc. Filed by: BRISTOL MYERS SQUIBB CO
Form 10-Q Ikena Oncology, Inc. For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.